TRUIST FINANCIAL CORP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$571,000
-69.7%
2,635
-83.8%
0.00%
-75.0%
Q4 2020$1,883,000
+3.3%
16,303
-13.0%
0.00%0.0%
Q3 2020$1,823,000
-2.3%
18,729
+23.2%
0.00%0.0%
Q2 2020$1,866,000
+82.0%
15,203
+29.9%
0.00%
+33.3%
Q1 2020$1,025,000
-22.3%
11,702
-7.3%
0.00%0.0%
Q4 2019$1,320,000
+528.6%
12,628
+591.6%
0.00%
-25.0%
Q3 2019$210,000
-32.9%
1,826
+0.5%
0.00%
-20.0%
Q2 2019$313,000
+22.3%
1,817
+19.7%
0.01%0.0%
Q1 2019$256,0001,5180.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders